Found 168 matching trials
Immunotherapy of Melanoma Patients
PHASE1The purpose of this study is to test whether vaccination with antigenic pep...
Location
Ludwig Institute for Cancer Research + Multidisciplinary Oncology Center at the Centre Hospitalier Universitaire Vaudois
A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer
PHASE1Background:
* PSA (prostate specific antigen) is a protein found on normal...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer
PHASE2The aim of Neo-POLEM is to determine the rate of Major Pathological Respons...
Location
The Queen Elizabeth Hospital
Serotonin Role on Brain Circuits Involved in Food Avoidance in Anorexia Nervosa
NASerotoninergic activity in brain structures involved in food control and av...
Location
CHU de Saint-Etienne
Testing the SurVaxM Vaccine for Lung Cancer Prevention
PHASE2This phase II trial tests how well a survivin peptide vaccine called SurVax...
Location
Rocky Mountain Regional VA Medical Center
Effects of a Mediterranean Diet With Cycling and Rowing Exercise on Blood Sugar in Women With Prediabetes
NAThe goal of this clinical trial is to learn how a Mediterranean-style diet,...
Location
Marmara University
Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults
PHASE1Part I:
12 subjects will receive an open-label 500 µl subcutaneous injecti...
Location
University Hospital Tuebingen
Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma
PHASE2This experiment will test the safety and effectiveness of a treatment for m...
Location
National Cancer Institute (NCI)
HER-2 B Cell Peptide Vaccine
PHASE1This phase I trial studies the side effects and best dose of vaccine therap...
Location
Indiana University Melvin & Bren Simon Comprehensive Cancer Center
Study of Cancer Peptides Vaccine Plus GM-CSF as Adjuvant Treatment for High Risk (TXN2-3M0) or Metastatic Breast Cancer With No Evidence of Disease
PHASE1This study will evaluate the safety and feasibility of administering a pept...
Location
Duke Comprehensive Cancer Center